Trial
NCT06438861
Role of Combination Therapy in Women With Refractory Overactive Bladder
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
Overactive Bladder Syndrome
Intervention
Vibegron 75mg
Why stopped
Not funded by industry
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-12